Overview
Splenic B-cell lymphoma, including splenic lymphoma with circulating villous lymphocytes (SLVL), is a rare hematological malignancy characterized by the proliferation of atypical B lymphocytes primarily affecting the spleen, often presenting with splenomegaly, hepatomegaly, and systemic symptoms like fever 1.Diagnosis
Morphological examination of peripheral blood and bone marrow smears is crucial 1.
Cytochemical and immunocytochemical studies help confirm the diagnosis 1.
Circulating villous lymphocytes are characteristic but not exclusive to SLVL 1.
Bone marrow biopsy may reveal infiltration by atypical lymphocytes 1.
Imaging studies (e.g., CT, MRI) can assess organ involvement and extent 1.Management
No specific first-line treatment regimen is detailed in the provided abstracts 1.
Management often involves supportive care and symptom control 1.
In cases requiring intervention, chemotherapy regimens similar to those used in other indolent lymphomas may be considered, though specific dosing is not provided 1.
Monitoring for complications such as infections is essential due to immunosuppression 1.Special Populations
Pediatrics: No specific information provided regarding pediatric cases 1.
Elderly: No particular considerations unique to elderly patients are mentioned 1.
Comorbidities: Management considerations for comorbidities are not detailed in the abstracts 1.Key Recommendations
Perform comprehensive morphological, cytochemical, and immunocytochemical analyses on peripheral blood and bone marrow samples for diagnosis 1 (Evidence: Weak).
Consider imaging studies to evaluate organ involvement and disease extent 1 (Evidence: Weak).
Implement supportive care measures and monitor for infections due to potential immunosuppression 1 (Evidence: Expert opinion).References
1 Gupta D, Rani S, Singh T, Madan S. Splenic lymphocytes with circulating villous lymphocytes--a case report. Indian journal of cancer 1996. link